Cargando…
UCP2 as a Potential Biomarker for Adjunctive Metabolic Therapies in Tumor Management
Glioblastoma (GBM) remains one of the most lethal primary brain tumors in both adult and pediatric patients. Targeting tumor metabolism has emerged as a promising-targeted therapeutic strategy for GBM and characteristically resistant GBM stem-like cells (GSCs). Neoplastic cells, especially those wit...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982524/ https://www.ncbi.nlm.nih.gov/pubmed/33763373 http://dx.doi.org/10.3389/fonc.2021.640720 |